Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 17 studies | 44% ± 17% | |
| basal cell | 14 studies | 36% ± 18% | |
| type I pneumocyte | 10 studies | 40% ± 14% | |
| club cell | 9 studies | 33% ± 14% | |
| secretory cell | 9 studies | 39% ± 10% | |
| enterocyte | 7 studies | 37% ± 12% | |
| goblet cell | 7 studies | 33% ± 16% | |
| respiratory goblet cell | 6 studies | 41% ± 20% | |
| ciliated cell | 6 studies | 33% ± 11% | |
| brush cell | 5 studies | 35% ± 5% | |
| ionocyte | 4 studies | 34% ± 12% | |
| squamous epithelial cell | 4 studies | 69% ± 16% | |
| progenitor cell | 4 studies | 32% ± 11% | |
| type II pneumocyte | 4 studies | 29% ± 12% | |
| luminal hormone-sensing cell of mammary gland | 4 studies | 23% ± 4% | |
| luminal cell of prostate epithelium | 4 studies | 23% ± 6% | |
| duct epithelial cell | 3 studies | 41% ± 6% | |
| hillock cell | 3 studies | 24% ± 10% | |
| conventional dendritic cell | 3 studies | 26% ± 5% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 32% ± 12% | |
| placental villous trophoblast | 3 studies | 88% ± 12% | |
| dendritic cell | 3 studies | 30% ± 2% | |
| pancreatic ductal cell | 3 studies | 58% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 99% | 4879.32 | 324 / 328 | 99% | 273.75 | 177 / 178 |
| thymus | 99% | 4046.82 | 648 / 653 | 92% | 228.41 | 557 / 605 |
| lung | 92% | 4839.45 | 532 / 578 | 99% | 253.23 | 1140 / 1155 |
| kidney | 100% | 7623.80 | 89 / 89 | 88% | 115.62 | 796 / 901 |
| prostate | 89% | 6703.27 | 217 / 245 | 99% | 257.04 | 499 / 502 |
| stomach | 74% | 5495.18 | 265 / 359 | 98% | 215.05 | 279 / 286 |
| breast | 58% | 4186.75 | 268 / 459 | 98% | 228.70 | 1100 / 1118 |
| intestine | 46% | 6098.07 | 441 / 966 | 98% | 234.49 | 518 / 527 |
| bladder | 43% | 2845.52 | 9 / 21 | 96% | 299.41 | 482 / 504 |
| esophagus | 40% | 9678.53 | 572 / 1445 | 99% | 250.16 | 181 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 242.34 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 282.77 | 1 / 1 |
| ovary | 1% | 8.73 | 1 / 180 | 98% | 282.99 | 423 / 430 |
| uterus | 6% | 382.56 | 11 / 170 | 89% | 258.57 | 408 / 459 |
| skin | 72% | 11850.35 | 1305 / 1809 | 20% | 16.63 | 93 / 472 |
| liver | 2% | 32.97 | 4 / 226 | 23% | 58.53 | 93 / 406 |
| eye | 0% | 0 | 0 / 0 | 23% | 14.32 | 18 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 9.65 | 6 / 29 |
| peripheral blood | 12% | 242.37 | 108 / 929 | 0% | 0 | 0 / 0 |
| spleen | 6% | 103.01 | 15 / 241 | 0% | 0 | 0 / 0 |
| brain | 4% | 66.19 | 106 / 2642 | 0% | 0.10 | 1 / 705 |
| adipose | 2% | 67.70 | 28 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 5.73 | 1 / 258 | 2% | 2.04 | 4 / 230 |
| blood vessel | 1% | 21.32 | 12 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 0% | 7.07 | 2 / 803 | 0% | 0 | 0 / 0 |
| heart | 0% | 2.10 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0060670 | Biological process | branching involved in labyrinthine layer morphogenesis |
| GO_0030198 | Biological process | extracellular matrix organization |
| GO_2000178 | Biological process | negative regulation of neural precursor cell proliferation |
| GO_0045687 | Biological process | positive regulation of glial cell differentiation |
| GO_0008544 | Biological process | epidermis development |
| GO_0060674 | Biological process | placenta blood vessel development |
| GO_0060429 | Biological process | epithelium development |
| GO_0071773 | Biological process | cellular response to BMP stimulus |
| GO_0001843 | Biological process | neural tube closure |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
| Gene name | SPINT1 |
| Protein name | Serine peptidase inhibitor, Kunitz type 1 Kunitz-type protease inhibitor 1 (Hepatocyte growth factor activator inhibitor type 1) (HAI-1) |
| Synonyms | UNQ223/PRO256 HAI1 |
| Description | FUNCTION: Inhibitor of HGFAC . Inhibits serine protease activity of ST14/matriptase in vitro . Inhibits serine protease activity of TMPRSS13, via the BPTI/Kunitz inhibitor 1 domain . . |
| Accessions | ENST00000562057.6 [O43278-2] ENST00000568580.5 H3BTQ8 O43278 H3BSM2 ENST00000568823.5 ENST00000344051.8 [O43278-1] H3BMB6 H3BNW5 H3BR01 ENST00000569589.1 ENST00000564375.5 ENST00000563656.5 ENST00000566928.5 H3BVD9 |